NRGN and Alzheimer disease: The increased levels of lysosomal proteins (i.e., cathepsin D and LAMP1) and decreased levels of synaptic proteins (synaptophysin, synaptopodin, synaptotagmin-2 and neurogranin) were also observed in the neuron-derived plasma exosomes of AD patients [145,146].